170 related articles for article (PubMed ID: 9284173)
1. In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies.
Elliot BC; Wisnewski AV; Johnson J; Fenwick-Smith D; Wiest P; Hamer D; Kresina T; Flanigan TP
Infect Immun; 1997 Sep; 65(9):3933-5. PubMed ID: 9284173
[TBL] [Abstract][Full Text] [Related]
2. Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.
Enriquez FJ; Riggs MW
Infect Immun; 1998 Sep; 66(9):4469-73. PubMed ID: 9712802
[TBL] [Abstract][Full Text] [Related]
3. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice.
Riggs MW; Cama VA; Leary HL; Sterling CR
Infect Immun; 1994 May; 62(5):1927-39. PubMed ID: 8168959
[TBL] [Abstract][Full Text] [Related]
4. Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo.
Doyle PS; Crabb J; Petersen C
Infect Immun; 1993 Oct; 61(10):4079-84. PubMed ID: 8406795
[TBL] [Abstract][Full Text] [Related]
5. Human monoclonal antibodies against Cryptosporidium parvum generated by hypo-osmolar electrofusion.
Flanigan TP; Wisnewski A; Wiest PM; Johnson J; Tzipori S; Hamer D; Lam N; Kresina TF
Trans Assoc Am Physicians; 1993; 106():86-90. PubMed ID: 8036749
[No Abstract] [Full Text] [Related]
6. Protective monoclonal antibodies define a distinct, conserved epitope on an apical complex exoantigen of Cryptosporidium parvum sporozoites.
Riggs MW; Yount PA; Stone AL; Langer RC
J Eukaryot Microbiol; 1996; 43(5):74S-75S. PubMed ID: 8822870
[No Abstract] [Full Text] [Related]
7. Characterization of new monoclonal antibodies against Cryptosporidium parvum sporozoites.
Camero L; Arrowood M; Shulaw W; Lal AA; Xiao L
J Eukaryot Microbiol; 1999; 46(5):58S-59S. PubMed ID: 10519248
[No Abstract] [Full Text] [Related]
8. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum.
Okhuysen PC; Chappell CL; Sterling CR; Jakubowski W; DuPont HL
Infect Immun; 1998 Feb; 66(2):441-3. PubMed ID: 9453592
[TBL] [Abstract][Full Text] [Related]
9. Elongation factor-1α is a novel protein associated with host cell invasion and a potential protective antigen of Cryptosporidium parvum.
Matsubayashi M; Teramoto-Kimata I; Uni S; Lillehoj HS; Matsuda H; Furuya M; Tani H; Sasai K
J Biol Chem; 2013 Nov; 288(47):34111-34120. PubMed ID: 24085304
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of recombinant Cryptosporidium parvum CpPRP1 sushi domain against C. tyzzeri infection in mice.
Huang Y; Cao W; Shi K; Mi R; Lu K; Han X; Chen Z
Parasite Immunol; 2017 Sep; 39(9):. PubMed ID: 28599077
[TBL] [Abstract][Full Text] [Related]
11. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.
Jenkins MC; O'Brien C; Trout J; Guidry A; Fayer R
Vaccine; 1999 May; 17(19):2453-60. PubMed ID: 10392628
[TBL] [Abstract][Full Text] [Related]
12. Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis.
Schaefer DA; Auerbach-Dixon BA; Riggs MW
Infect Immun; 2000 May; 68(5):2608-16. PubMed ID: 10768951
[TBL] [Abstract][Full Text] [Related]
13. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites.
Riggs MW; Stone AL; Yount PA; Langer RC; Arrowood MJ; Bentley DL
J Immunol; 1997 Feb; 158(4):1787-95. PubMed ID: 9029117
[TBL] [Abstract][Full Text] [Related]
14. Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G.
Chappell CL; Okhuysen PC; Sterling CR; Wang C; Jakubowski W; Dupont HL
Am J Trop Med Hyg; 1999 Jan; 60(1):157-64. PubMed ID: 9988341
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivities with Cryptosporidium spp. by chicken monoclonal antibodies that recognize avian Eimeria spp.
Matsubayashi M; Kimata I; Iseki M; Lillehoj HS; Matsuda H; Nakanishi T; Tani H; Sasai K; Baba E
Vet Parasitol; 2005 Mar; 128(1-2):47-57. PubMed ID: 15725532
[TBL] [Abstract][Full Text] [Related]
16. Specific IgA antibody response to coproantigens of Cryptosporidium parvum in serum and saliva of calves after experimental infection.
Toyoguchi A; Omata Y; Koyama T; Kamiyoshi T; Furuoka H; Kobayashi Y; Kakuda F; Maeda R; Saito A; Mikami T
Vet Parasitol; 2001 Apr; 96(3):213-20. PubMed ID: 11240095
[TBL] [Abstract][Full Text] [Related]
17. Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis.
Cozon G; Biron F; Jeannin M; Cannella D; Revillard JP
J Infect Dis; 1994 Mar; 169(3):696-9. PubMed ID: 8158056
[TBL] [Abstract][Full Text] [Related]
18. [Cryptosporidium parvum in patients with chronic diarrhea and AIDS: diagnosis by means of indirect immunofluorescence with monoclonal antibodies].
Weitz JC; Astorga B
Rev Med Chil; 1993 Aug; 121(8):923-6. PubMed ID: 8296101
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Cryptosporidium parvum infection of a mammalian cell culture by recombinant scFv antibodies.
Pokorny NJ; Boulter-Bitzer JI; Hall JC; Trevors JT; Lee H
Antonie Van Leeuwenhoek; 2008 Oct; 94(3):353-64. PubMed ID: 18581250
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Cryptosporidium parvum and Cryptosporidium wrairi by reactivity with monoclonal antibodies and ability to infect severe combined immunodeficient mice.
Chrisp CE; Mason P; Perryman LE
Infect Immun; 1995 Jan; 63(1):360-2. PubMed ID: 7806379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
